ABBOTT LABORATORIES (ABT) Capital expenditures 2016–2025
ABBOTT LABORATORIES (ABT) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$2.2BFY2025 · since FY2016: $1.1B → $2.2B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.2B | -1.6% |
| FY2024 | $2.2B | +0.2% |
| FY2023 | $2.2B | +23.9% |
| FY2022 | $1.8B | -5.7% |
| FY2021 | $1.9B | -13.4% |
| FY2020 | $2.2B | +32.9% |
| FY2019 | $1.6B | +17.5% |
| FY2018 | $1.4B | +22.8% |
| FY2017 | $1.1B | +1.2% |
| FY2016 | $1.1B | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice